| TRIM33 promotes glycolysis through regulating P53 K48-linked ubiquitination to promote esophageal squamous cell carcinoma growth. | TRIM33 promotes glycolysis through regulating P53 K48-linked ubiquitination to promote esophageal squamous cell carcinoma growth.
Xia T, Meng L, Xu G, Sun H, Chen H., Free PMC Article | 10/21/2024 |
| TRIM33 enhances the ubiquitination of TFRC to enhance the susceptibility of liver cancer cells to ferroptosis. | TRIM33 enhances the ubiquitination of TFRC to enhance the susceptibility of liver cancer cells to ferroptosis.
Ji W, Zhang W, Zhang X, Ke Y. | 08/3/2024 |
| TRIM33 loss in multiple myeloma is associated with genomic instability and sensitivity to PARP inhibitors. | TRIM33 loss in multiple myeloma is associated with genomic instability and sensitivity to PARP inhibitors.
McAvera RM, Morgan JJ, Herrero AB, Mills KI, Crawford LJ., Free PMC Article | 04/22/2024 |
| TIF1gamma and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis. | TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
Wu Y, Yu B, Ai X, Zhang W, Chen W, Laurence A, Zhang M, Chen Q, Shao Y, Zhang B. | 04/2/2024 |
| Tripartite motif containing 33 demonstrated anticancer effect by degrading c-Myc: Limitation of glutamine metabolism and proliferation in endometrial carcinoma cells. | Tripartite motif containing 33 demonstrated anticancer effect by degrading c‑Myc: Limitation of glutamine metabolism and proliferation in endometrial carcinoma cells.
Qi Y, Ma N, Zhang J., Free PMC Article | 11/13/2023 |
| Tubular cell transcriptional intermediary factor 1gamma deficiency exacerbates kidney injury-induced tubular cell polyploidy and fibrosis. | Tubular cell transcriptional intermediary factor 1γ deficiency exacerbates kidney injury-induced tubular cell polyploidy and fibrosis.
Yuan C, Jin G, Li P, Wang W, Ge C, Pan Y, Zhang Q, Mo J, Kuang D, Liu L, Zhang X, Liang H, Zhang W, Tang X, Li Z, Liu J, Xu G, Chen X, Ding ZY, Zhang B. | 09/28/2023 |
| E3 ubiquitin ligase Trim33 ubiquitylates Annexin A2 to promote NF-kappaB induced skin inflammation in psoriasis. | E3 ubiquitin ligase Trim33 ubiquitylates Annexin A2 to promote NF-κB induced skin inflammation in psoriasis.
Zhang J, Zhu J, Chen X, Xia H, Yang L. | 10/15/2022 |
| Downregulation of TRIM33 Promotes Survival and Epithelial-Mesenchymal Transition in Gastric Cancer. | Downregulation of TRIM33 Promotes Survival and Epithelial-Mesenchymal Transition in Gastric Cancer.
Wang F, Wang W, Wu X, Tang C, Du F, Lu Z, Zhang Z, Xu H, Cao X, Li PA., Free PMC Article | 08/27/2022 |
| TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.
Chen M, Lingadahalli S, Narwade N, Lei KMK, Liu S, Zhao Z, Zheng Y, Lu Q, Tang AHN, Poon TCW, Cheung E., Free PMC Article | 08/13/2022 |
| KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast Cancer. | KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast Cancer.
Yu B, Luo F, Sun B, Liu W, Shi Q, Cheng SY, Chen C, Chen G, Li Y, Feng H., Free PMC Article | 02/26/2022 |
| TRIM33 protects osteoblasts from oxidative stress-induced apoptosis in osteoporosis by inhibiting FOXO3a ubiquitylation and degradation. | TRIM33 protects osteoblasts from oxidative stress-induced apoptosis in osteoporosis by inhibiting FOXO3a ubiquitylation and degradation.
Zou DB, Mou Z, Wu W, Liu H., Free PMC Article | 02/5/2022 |
| Alteration of TRIM33 Expression at Transcriptional and Translational Levels is Correlated with Autism Symptoms. | Alteration of TRIM33 Expression at Transcriptional and Translational Levels is Correlated with Autism Symptoms.
Norouzi Ofogh S, Rasoolijazi H, Shahsavand Ananloo E, Shahrivar Z, Joghataei MT, Sadeghi B, Bozorgmehr A, Alizadeh F. | 01/15/2022 |
| TRIM33 gene somatic mutations identified by next generation sequencing in neoplasms of patients with anti-TIF1gamma positive cancer-associated dermatomyositis. | TRIM33 gene somatic mutations identified by next generation sequencing in neoplasms of patients with anti-TIF1γ positive cancer-associated dermatomyositis.
Cordel N, Derambure C, Coutant S, Mariette X, Jullien D, Debarbieux S, Chosidow O, Meyer A, Bessis D, Joly P, Mathian A, Levesque H, Sabourin JC, Tournier I, Boyer O, OncoMyositis Study group. | 01/1/2022 |
| PIAS1 and TIF1gamma collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition. | PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.
Chanda A, Ikeuchi Y, Karve K, Sarkar A, Chandhoke AS, Deng L, Bonni A, Bonni S., Free PMC Article | 12/25/2021 |
| TRIM33 prevents pulmonary fibrosis by impairing TGF-beta1 signalling. | TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling.
Boutanquoi PM, Burgy O, Beltramo G, Bellaye PS, Dondaine L, Marcion G, Pommerolle L, Vadel A, Spanjaard M, Demidov O, Mailleux A, Crestani B, Kolb M, Garrido C, Goirand F, Bonniaud P. | 05/29/2021 |
| TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro. | TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.
Xu Y, Wu G, Zhang J, Li J, Ruan N, Zhang J, Zhang Z, Chen Y, Zhang Q, Xia Q., Free PMC Article | 05/22/2021 |
| Trim24 and Trim33 Play a Role in Epigenetic Silencing of Retroviruses in Embryonic Stem Cells. | Trim24 and Trim33 Play a Role in Epigenetic Silencing of Retroviruses in Embryonic Stem Cells.
Margalit L, Strauss C, Tal A, Schlesinger S., Free PMC Article | 03/6/2021 |
| Hepatic stellate cell-specific knockout of transcriptional intermediary factor 1gamma aggravates liver fibrosis. | Hepatic stellate cell-specific knockout of transcriptional intermediary factor 1γ aggravates liver fibrosis.
Lee EJ, Hwang I, Lee JY, Park JN, Kim KC, Kim I, Moon D, Park H, Lee SY, Kim HS, Jun DW, Park SH, Kim HS., Free PMC Article | 02/20/2021 |
| Direct measurement of protein-protein interactions by FLIM-FRET at UV laser-induced DNA damage sites in living cells. | Direct measurement of protein-protein interactions by FLIM-FRET at UV laser-induced DNA damage sites in living cells.
Kaufmann T, Herbert S, Hackl B, Besold JM, Schramek C, Gotzmann J, Elsayad K, Slade D., Free PMC Article | 12/26/2020 |
| we have shown that TRIM33 deficiency in myeloid cells during colitis is associated with increased production of blood monocytes, a defect in monocytes recruitment and differentiation into functional macrophages leading to failure to resolve intestinal inflammation. | TRIM33 deficiency in monocytes and macrophages impairs resolution of colonic inflammation.
Petit V, Parcelier A, Mathé C, Barroca V, Torres C, Lewandowski D, Ferri F, Gallouët AS, Dalloz M, Dinet O, Boschetti G, Vozenin MC, Roméo PH., Free PMC Article | 12/21/2019 |
| These findings support the potential of using measurements of Tif1gamma plasma levels to guide breast cancer therapy and monitoring. Further studies are required to validate Tif1gamma as an easily detectable, noninvasive prognostic biomarker for breast cancer. | Prognostic role of Tif1γ expression and circulating tumor cells in patients with breast cancer.
Cai F, Cai L, Zhou Z, Pan X, Wang M, Chen S, Luis MAF, Cen C, Biskup E., Free PMC Article | 08/3/2019 |
| The expression of TIF1gamma in the muscle of idiopathic inflammatory myopathies was related to the positivity for serum anti-TIF1gamma antibody and presence of tubuloreticular bodies in the muscle biopsies. | Anti-TIF1γ antibody and the expression of TIF1γ in idiopathic inflammatory myopathies.
Kim Y, Song KS, Sohn EH, Kang SW, Yoo IS, Shim SC, Yoo SJ, Kim J. | 06/15/2019 |
| Our findings show that circPTK2 (hsa_circ_0008305) inhibits TGF-beta-induced EMT and metastasis by controlling TIF1gamma in NSCLC, revealing a novel mechanism by which circRNA regulates TGF-beta-induced EMT and tumor metastasis, and suggesting that circPTK2 overexpression could provide a therapeutic strategy for advanced NSCLC. | Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
Wang L, Tong X, Zhou Z, Wang S, Lei Z, Zhang T, Liu Z, Zeng Y, Li C, Zhao J, Su Z, Zhang C, Liu X, Xu G, Zhang HT., Free PMC Article | 04/27/2019 |
| TRIM33 acts as a cellular factor restricting HIV-1 infection by preventing provirus formation. | Cellular TRIM33 restrains HIV-1 infection by targeting viral integrase for proteasomal degradation.
Ali H, Mano M, Braga L, Naseem A, Marini B, Vu DM, Collesi C, Meroni G, Lusic M, Giacca M., Free PMC Article | 04/20/2019 |
| Not only did anti-TIF1gamma antibodies correlate strongly with malignancy in dermatomyositis patients, but cancers were also significantly more advanced in anti-TIF1gamma-positive DM patients than in anti-TIF1gamma-negative patients. | Strong correlation between cancer progression and anti-transcription intermediary factor 1γ antibodies in dermatomyositis patients.
Ogawa-Momohara M, Muro Y, Mitsuma T, Katayama M, Yanaba K, Nara M, Kakeda M, Kono M, Akiyama M. | 03/9/2019 |